Dr. Marcus Morawietz

Dr. Marcus Morawietz

Frankfurt

Dr. Marcus Morawietz is an advisor to executives in the chemicals industry for Strategy&, PwC’s strategy consulting group. He is a Managing Director Strategy& Germany, based in Frankfurt. He focuses on strategy, innovation, and operations along the entire chemical value chain. He has more than 17 years of joint consulting and industry experience and is a member of the leadership team of our European Energy, Chemicals and Utilities, and Operations practices.

His key areas of focus are:

  • Growth strategy
  • Innovation
  • Business model transformation
  • Manufacturing and supply-chain improvement
  • Transaction support
  • Restructuring

Examples of Marcus Morawietz’s recent assignments include:

  • Growth Strategy — He has led several projects on growth strategies, market entry strategies and portfolio optimizations for leading chemical companies on global base. In a recent project, a growth strategy for a leading specialty chemical player has been elaborated including portfolio optimization, innovative pricing models and significant cost reduction. Conducting a stringent implementation of the revised strategy achieved a strong performance improvement on a sustainable basis.
  • Operations Improvement — Marcus Morawietz has led several operations improvement assignments (asset effectiveness, supply-chain optimization, strategic sourcing) in the chemical and pharma industry. A recent project focused on optimizing a pharma asset network including network consolidation, redesign of value chain coverage/make-or-buy and efficiency and effectiveness improvement of the manufacturing sites. The large joint client/consultant team developed the entire operations strategy and supported the implementation and change management.
  • Transaction Support — He has led several assignments supporting different stages of transactions ranging from due diligences, pre- and post-merger integrations as well as restructurings. These projects have been key levers in growth strategies of large chemical and pharma companies as well as financial investors.

Prior to joining Strategy&, he was Principal at A. T. Kearney and worked for Degussa (today Evonik) in several management positions. He holds a PhD and diploma degree in chemicals from the Technical University of Munich.

Authored articles

  • 2017 Chemicals Trends

    Conclusion

    Uncertainty is certainly the new normal in the chemicals industry. And although the sector has historically swung like a pendulum between good times and bad, it no longer appears likely it will return to robust profitability on the wings of a new, innovative product segment or the unexpected opening of a new market. It has been decades since either of those scenarios played out. There are, however, strategic steps that chemicals companies can take to at least open doors to profitable growth, including value capture, digitization, and smarter portfolio management. But given the unsettled conditions in the industry, they can’t afford to delay in playing their best hands.

  • 2016 Chemicals Industry Trends2016 Chemicals Industry TrendsThe #chemicals industry had a tough 2015. What lies ahead for 2016? via @strategyand http://strat.to/Y5CSO
  • 2015 Chemicals TrendsGrowth in #chemicals will come from #emergingmarkets in 2015, where many cos have been losing to local players: Why? via @strategyand http://strat.to/HbJPJ
  • Future of chemicals IX: How M&A will shape the competitive landscape
  • Chemicals: Deploy Natural Supply Chains